Fiscal Year Earnings Estimate on Alliqua BioMedical, Inc.(ALQA)

Alliqua BioMedical, Inc.(ALQA): For the most recent quarter end, Alliqua BioMedical, Inc. reported Annual Earnings of $-0.2. Based on the filings, last years Annual Earnings was, $-1.09. For the most recent quarter end, ALQA reported a surprise Earnings per Share of 16.67% . The consensus estimate for current quarter is $-0.21 and for the current fiscal year, the estimate is $-1.02. For the Next fiscal year, the estimate is $-0.61 based on the consensus.

Alliqua BioMedical, Inc. has received $-0.21 as the consensus Earnings Estimate for the Quarter ending on Dec 2016 ,According to the estimate provided by 3 Financial Advisor in the Stock Trading Firms. Among 3 Analysts, Bottom line EPS Estimate for the current quarter is $-0.24 while the top line estimate is $-0.16 , a key information to consider for Day Trading and investing in stocks. The EPS growth rate is projected at 16%. Alliqua BioMedical, Inc. reported better than expected with a surprise EPS of 16.67% or $0.04 during its most recent quarterly earnings. The Actual EPS was $-0.2 compared to the Estimated EPS of $-0.24.

Company has reported several Insider transactions to the SEC, on Nov 12, 2015, Jeffrey Sklar (director) purchased 1,500 shares at 2.95 per share price.On Nov 10, 2015, Brian M Posner (CFO) purchased 5,000 shares at 3.04 per share price.On Nov 9, 2015, Bradford Barton (COO) purchased 5,000 shares at 2.97 per share price.

Alliqua BioMedical, Inc. (NASDAQ:ALQA) rose 0.85% or 0.0041 points on Wednesday and made its way into the gainers of the day. After trading began at $0.4736 the stock was seen hitting $0.525 as a peak level and $0.46 as the lowest level. The stock ended up at $0.484. The daily volume was measured at 1,032,351 shares. The 52-week high of the share price is $1.48 and the 52-week low is $0.45. The company has a market cap of $14 million.

Alliqua, Inc. is a biomedical company. The company focused on the development, manufacturing and distribution of proprietary transdermal wound care and drug delivery technologies. Its technology platform produces hydrogels, a 3-dimensional cross-linked network of water soluble polymers. The companys product includes SilverSeal(R) a hydrogel wound dressing with silver coated fibers and Hydress(R) an over-the-counter hydrogel wound dressing. It serves the healthcare industry including wound healing, medical diagnostics and cosmeceuticals. Alliqua, Inc. is headquartered in Langhorne, Pennsylvania.


Add Comment